Area of Research: PARP Inhibitors
2021 Grant Recipients
-
Sridevi Challa, PhD,
UT Southwestern Medical Center
Mentored Investigator GrantRole of Ribosomal Protein Mono(ADP-ribosyl)ation in Protein Quality Control
-
Benoît Bragantini, PhD,
Mayo Clinic
Mentored Investigator GrantProbing Homologous Recombination DNA Repair Factors in Chromatin by cryo-EM
-
Ichiko Kinjyo, MD, PhD,
University of New Mexico
Early Career Investigator GrantA Novel Mechanism for the Immunomodulatory Effects of PARP-inhibitor
-
Arun Kanakkanthara, PhD,
Mayo Clinic
Early Career Investigator GrantExploiting a Metabolic Dependency of PARPinhibitor-Resistant Ovarian Cancer
-
Liya Ding, PhD,
Dana Farber Cancer Institute
Early Career Investigator GrantTargeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer
-
Ivan Ahel, PhD,
University of Oxford
Collaborative Research Development GrantExploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy
2020 Grant Recipients
-
Nidhi Sahni, PhD,
MD Anderson Cancer Center
Early Career Investigator GrantSystems Approach for PARP-based Novel Combination Therapy in Ovarian Cancer
-
Janice Santiago, PhD,
MD Anderson Cancer Center
Mentored Investigator GrantCrizotinib Improves the Therapeutic Efficacy of Olaparib in Ovarian Cancer
2019 Grant Recipients
-
Sarah Gitto, PhD,
University of Pennsylvania
Mentored Investigator GrantModeling Autologous TIL Therapy in Novel PARP Resistant PDX Model for Ovarian Cancer
-
Marilyne Labrie, PhD,
Oregon Health and Science University
Mentored Investigator GrantSynergistic Lethality of PARP and P13K Pathway Inhibitors in Ovarian Cancer
-
Shariska Petersen, MD,
University of Kansas Medical Center Research Institute
Mentored Investigator GrantCyclin E and BRD4 as Markers for a New PARPi Drug Combination
2018 Grant Recipients
-
Shih-Hsun Chen, PhD,
Beckman Research Institute of the City of Hope
Mentored Investigator GrantTargeting de-poly (ADP-ribosyl)ation for Ovarian Cancer Therapy
-
Maria Victoria Botuyan, PhD,
Mayo Clinic
Early Career Investigator GrantProbing the Antagonistic Roles of 53BP1 and RAD18 in HR DNA Repair
-
Jian Yuan, PhD,
Mayo Clinic
Early Career Investigator GrantThe Role of BRD9-Rad51 Axis in Chemoresistance in Ovarian Cancer
2017 Grant Recipients
-
Anniina Farkkila, MD, PhD,
Dana Farber Cancer Institute
Mentored Investigator GrantOvercoming PARP Inhibitor Resistance in Ovarian Cancer
2015 Grant Recipients
-
Sarah Adams, MD,
University of New Mexico
Early Career Investigator GrantA Combination Therapy for Hereditary Ovarian Cancer
2014 Grant Recipients
-
Barbara Stulken Norquist, MD,
University of Washington
Early Career Investigator GrantMolecular Biomarkers to Predict PARP Inhibitor Response in Ovarian Cancer
-
Mo Li, PhD,
University of Michigan
Mentored Investigator GrantMechanism of PARP Inhibitor in Ovarian Cancer Therapy Cancer
2013 Grant Recipients
-
Elizabeth Swisher, MD,
University of Washington
Collaborative Research Development GrantThe FA-BRCA Pathway and Response to Platinum and PARP Inhibitors in Ovarian, Tubal and Peritoneal Carcinomas
2012 Grant Recipients
-
See-Hyoung Park, PhD,
Stanford University
Mentored Investigator GrantTargeting Ovarian Cancer with Combination of Olaparib and Bepridil
2011 Grant Recipients
-
Sarah Adams, MD,
University of Pennsylvania
Early Career Investigator GrantDevelopment of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer
2008 Grant Recipients
-
Lejla Delic, MD,
Cedars-Sinai Medical Center
Mentored Investigator GrantA New Class of Drugs with Potential Against Ovarian Cancer: PARP-inhibitors